These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38007091)

  • 21. Comparative Study of Pulpal Responses to Pulpotomy with ProRoot MTA, RetroMTA, and TheraCal in Dogs' Teeth.
    Lee H; Shin Y; Kim SO; Lee HS; Choi HJ; Song JS
    J Endod; 2015 Aug; 41(8):1317-24. PubMed ID: 26015158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of MTA and Biodentine as medicaments for pulpotomy in traumatized anterior immature permanent teeth: A randomized clinical trial.
    Abuelniel GM; Duggal MS; Kabel N
    Dent Traumatol; 2020 Aug; 36(4):400-410. PubMed ID: 32096595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized clinical trial of pulpotomy using a premixed injectable calcium silicate cement on mature permanent teeth with reversible pulpitis.
    Cho SY; Park S; Shin Y; Jung IY
    Sci Rep; 2024 Feb; 14(1):2994. PubMed ID: 38316823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dental Pulp Response to RetroMTA after Partial Pulpotomy in Permanent Human Teeth.
    Bakhtiar H; Aminishakib P; Ellini MR; Mosavi F; Abedi F; Esmailian S; Esnaashari E; Nekoofar MH; Sezavar M; Mesgarzadeh V; About I
    J Endod; 2018 Nov; 44(11):1692-1696. PubMed ID: 30241682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Success rate of permanent teeth pulpotomy using bioactive materials: A systematic review and meta-analysis of randomized clinical trials.
    Silva EJNL; Pinto KP; Belladonna FG; Ferreira CMA; Versiani MA; De-Deus G
    Int Endod J; 2023 Sep; 56(9):1024-1041. PubMed ID: 37254176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies.
    Celik B; Ataç AS; Cehreli ZC; Uysal S
    J Dent Child (Chic); 2013; 80(3):126-32. PubMed ID: 24351693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of bacterial leakage and marginal adaptation of the bioceramics pulp dressing materials: an invitro study.
    Snigdha NTS; Kamarudin A; Baharin F; Ghani NRNA; Bin Yhaya MF; Ahmad WMAW; Karobari MI
    BMC Oral Health; 2023 Jul; 23(1):462. PubMed ID: 37420224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial of various MTA materials for partial pulpotomy in permanent teeth.
    Kang CM; Sun Y; Song JS; Pang NS; Roh BD; Lee CY; Shin Y
    J Dent; 2017 May; 60():8-13. PubMed ID: 27472957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium hydroxide vs mineral trioxide aggregates for partial pulpotomy of permanent molars with deep caries.
    Qudeimat MA; Barrieshi-Nusair KM; Owais AI
    Eur Arch Paediatr Dent; 2007 Jun; 8(2):99-104. PubMed ID: 17555692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vital pulp therapy following pulpotomy in immature first permanent molars with deep caries using novel fast-setting calcium silicate cement: A retrospective clinical study.
    Vafaei A; Nikookhesal M; Erfanparast L; Løvschall H; Ranjkesh B
    J Dent; 2022 Jan; 116():103890. PubMed ID: 34780875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tomographic Evaluation of the Internal Adaptation for Recent Calcium Silicate-Based Pulp Capping Materials in Primary Teeth.
    Al Tuwirqi AA; El Ashiry EA; Alzahrani AY; Bamashmous N; Bakhsh TA
    Biomed Res Int; 2021; 2021():5523145. PubMed ID: 34046496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial.
    Asgary S; Eghbal MJ
    Acta Odontol Scand; 2013 Jan; 71(1):130-6. PubMed ID: 22339289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of several intracanal medicaments on the push-out bond strength of ProRoot MTA and Biodentine.
    Nagas E; Cehreli ZC; Uyanik MO; Vallittu PK; Lassila LV
    Int Endod J; 2016 Feb; 49(2):184-8. PubMed ID: 25631153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reinforcing Effect of Glass Fiber-incorporated ProRoot MTA and Biodentine as Intraorifice Barriers.
    Nagas E; Cehreli ZC; Uyanik O; Vallittu PK; Lassila LV
    J Endod; 2016 Nov; 42(11):1673-1676. PubMed ID: 27639639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in permanent teeth with incomplete root development: a randomized controlled trial.
    Keswani D; Pandey RK; Ansari A; Gupta S
    J Endod; 2014 May; 40(5):599-605. PubMed ID: 24767550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars.
    Juneja P; Kulkarni S
    Eur Arch Paediatr Dent; 2017 Aug; 18(4):271-278. PubMed ID: 28780718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying Coronal Permanent Tooth Discoloration Caused by Different Pulpotomy Materials.
    Azem H; Blumer S; Peretz B; Haj-Yahya S; Elbahary S
    J Clin Pediatr Dent; 2021 Nov; 45(5):306-311. PubMed ID: 34740264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
    Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - part II: other clinical applications and complications.
    Torabinejad M; Parirokh M; Dummer PMH
    Int Endod J; 2018 Mar; 51(3):284-317. PubMed ID: 28846134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.